StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Vikas Salunkhe, Nirmal Bang Securities

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byVikas Salunkhe, Nirmal Bang SecuritiesHorizon: NA (inferred Swing (≤2wk))19 Aug 2026via CNBC Awaaz.

Entry₹1,892.6Inferred
Target₹1,960
Total upside +3.56% (call closed)
Stop lossNot given
Exit₹1,96031 Aug 2026, 3:30 pm
Target hit+3.56%0.00%upside left
Follow Vikas Salunkhe for new calls(23% target hit, 115 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 222 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 31 Aug 2026
2 supporting0 opposing
Supports the BUY call (2)

Sun Pharma and its subsidiaries have won an antitrust litigation in the US related to the Lipitor patent settlement. The US Court of Appeals affirmed a summary judgment in their favor, denying class c

BSE · Company Update·17 Aug · 2w ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·30 Jul · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Vikas Salunkhe, Nirmal Bang Securities

Every call and its outcome